Silverback Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Silverback Therapeutics by Tower Research Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $481k | 46k | 10.55 |
2024-09-30 | $62k | 4.3k | 14.50 |
2024-06-30 | $65k | 7.7k | 8.51 |
2024-03-31 | $2.4k | 231 | 10.22 |
2023-09-30 | $135k | 36k | 3.78 |
2023-06-30 | $64k | 9.5k | 6.70 |
2023-03-31 | $64k | 9.7k | 6.63 |
2022-12-31 | $71k | 8.2k | 8.64 |
2022-09-30 | $33k | 6.6k | 5.05 |
2022-06-30 | $45k | 11k | 4.26 |
2022-03-31 | $70k | 20k | 3.52 |
2021-12-31 | $19k | 2.8k | 6.80 |
2021-09-30 | $53k | 4.6k | 11.67 |
2021-06-30 | $34k | 1.1k | 31.02 |
2021-03-31 | $29k | 657 | 44.14 |